| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of RUNX2 mRNA" | 12021203 |
| C119129 | 18alpha-glycyrrhetinic acid | 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of RUNX2 protein] | 21910061 |
| C119129 | 18alpha-glycyrrhetinic acid | 18alpha-glycyrrhetinic acid inhibits the reaction [RUNX2 protein results in increased expression of ALPL mRNA] | 21910061 |
| C119129 | 18alpha-glycyrrhetinic acid | 18alpha-glycyrrhetinic acid inhibits the reaction [RUNX2 protein results in increased expression of BGLAP mRNA] | 21910061 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in increased expression of RUNX2 mRNA" | 20453058 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RUNX2 mRNA" | 25510870 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of RUNX2 mRNA" | 23829299 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of RUNX2 mRNA] | 17689939 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of RUNX2 mRNA | 17689939 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [arsenic trioxide results in decreased expression of RUNX2] | 24531206 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased expression of RUNX2 mRNA] | 26053266|2613693 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | [pyrazolanthrone co-treated with SB 203580 co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] inhibits the reaction [Quercetin results in increased expression of RUNX2 mRNA] | 26136938 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RUNX2 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RUNX2 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RUNX2 mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RUNX2 mRNA" | 25510870 |
| C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RUNX2 mRNA] | 23625689 |
| C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased expression of RUNX2 mRNA | 23625689 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quercetin results in increased expression of RUNX2 mRNA] | 26053266 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased phosphorylation of RUNX2 protein]" | 20458730 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Bezafibrate results in increased expression of RUNX2 mRNA]" | 21499286 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of RUNX2 mRNA | 29067470 |
| C056165 | acetovanillone | acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of RUNX2 mRNA] | 24080574 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of RUNX2 mRNA] | 19017541 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Dexamethasone affects the expression of RUNX2 mRNA] | 24239970 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of RUNX2 gene | 27153756 |
| D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in decreased expression of RUNX2 mRNA | 28522335 |
| C010845 | aluminum chloride | [Sodium Fluoride co-treated with aluminum chloride] results in increased expression of RUNX2 mRNA | 21560300 |
| C010845 | aluminum chloride | aluminum chloride results in decreased expression of RUNX2 mRNA | 27470910 |
| C010845 | aluminum chloride | ginsenoside Rb1 inhibits the reaction [aluminum chloride results in decreased expression of RUNX2 mRNA] | 27470910 |
| D005680 | gamma-Aminobutyric Acid | gamma-Aminobutyric Acid affects the expression of RUNX2 mRNA | 24098073 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of RUNX2 mRNA | 16483693 |
| C088115 | anacardic acid | anacardic acid inhibits the reaction [Tretinoin results in increased expression of RUNX2 mRNA] | 24819975 |
| D001151 | Arsenic | Arsenic affects the methylation of RUNX2 gene | 25304211 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of RUNX2 mRNA | 20458559 |
| C006632 | arsenic trioxide | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [arsenic trioxide results in decreased expression of RUNX2] | 24531206 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of RUNX2 | 24531206 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of RUNX2 mRNA | 22465848 |
| C015001 | arsenite | arsenite results in increased methylation of RUNX2 promoter | 23974009 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of RUNX2 mRNA" | 18687144 |
| D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA | 26424790 |
| D001205 | Ascorbic Acid | Ascorbic Acid results in increased expression of RUNX2 mRNA | 28105418 |
| D001205 | Ascorbic Acid | [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of RUNX2 mRNA | 17692823 |
| D001205 | Ascorbic Acid | EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA] | 26424790 |
| D001205 | Ascorbic Acid | Ascorbic Acid results in increased expression of RUNX2 mRNA | 20530736 |
| D001205 | Ascorbic Acid | U 0126 inhibits the reaction [Ascorbic Acid results in increased expression of RUNX2 mRNA] | 20530736 |
| D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein | 27387537 |
| D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with Phosphates] results in increased expression of RUNX2 mRNA | 21613385 |
| D001205 | Ascorbic Acid | [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA | 27028516 |
| D001205 | Ascorbic Acid | Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein] | 27387537 |
| D001205 | Ascorbic Acid | ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]] | 27387537 |
| D001205 | Ascorbic Acid | Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA] | 27028516 |
| D001205 | Ascorbic Acid | NOG protein inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]]] | 27387537 |
| D001205 | Ascorbic Acid | Quercetin affects the reaction [Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA]] | 27028516 |
| D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with IL11 protein] results in increased expression of RUNX2 mRNA | 17956465 |
| D001205 | Ascorbic Acid | Ascorbic Acid results in increased expression of RUNX2 mRNA | 17274723 |
| C547126 | AZM551248 | AZM551248 results in increased expression of RUNX2 mRNA | 22323515 |
| D001554 | Benzene | Benzene results in increased expression of RUNX2 mRNA | 22960397 |
| D001554 | Benzene | Benzene results in decreased expression of RUNX2 mRNA | 15120971 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of RUNX2 mRNA" | 20382639 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RUNX2 mRNA" | 19150397 |
| D001599 | Berberine | Berberine results in increased expression of RUNX2 mRNA | 26478571 |
| D001599 | Berberine | CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of RUNX2 mRNA] | 26478571 |
| D001599 | Berberine | DKK1 protein inhibits the reaction [Berberine results in increased expression of RUNX2 mRNA] | 26478571 |
| D004958 | Estradiol | EGF protein promotes the reaction [Estradiol results in increased expression of RUNX2 mRNA] | 24758408 |
| D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in decreased expression of RUNX2 mRNA | 20660070 |
| D004958 | Estradiol | Estradiol results in increased expression of RUNX2 mRNA | 16202921|1768993 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased expression of RUNX2 mRNA] | 17689939 |
| D004958 | Estradiol | Estradiol affects the expression of RUNX2 mRNA | 17166402 |
| C031463 | beta-glycerophosphoric acid | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA | 26424790 |
| C031463 | beta-glycerophosphoric acid | [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of RUNX2 mRNA | 17692823 |
| C031463 | beta-glycerophosphoric acid | EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA] | 26424790 |
| C031463 | beta-glycerophosphoric acid | [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein | 27387537 |
| C031463 | beta-glycerophosphoric acid | [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA | 27028516 |
| C031463 | beta-glycerophosphoric acid | Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein] | 27387537 |
| C031463 | beta-glycerophosphoric acid | ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]] | 27387537 |
| C031463 | beta-glycerophosphoric acid | Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA] | 27028516 |
| C031463 | beta-glycerophosphoric acid | NOG protein inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]]] | 27387537 |
| C031463 | beta-glycerophosphoric acid | Quercetin affects the reaction [Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA]] | 27028516 |
| D001629 | Bezafibrate | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Bezafibrate results in increased expression of RUNX2 mRNA]" | 21499286 |
| D001629 | Bezafibrate | Bezafibrate results in increased expression of RUNX2 mRNA | 21499286 |
| D001629 | Bezafibrate | GSK0660 inhibits the reaction [Bezafibrate results in increased expression of RUNX2 mRNA] | 21499286 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [FGF2 protein results in increased expression of RUNX2 mRNA] | 12403780 |
| C006780 | bisphenol A | bisphenol A affects the methylation of RUNX2 promoter | 27334623 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of RUNX2 mRNA | 23900028 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of RUNX2 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of RUNX2 gene | 28505145 |
| C032688 | boric acid | boric acid affects the expression of RUNX2 mRNA | 24704097 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of RUNX2 protein | 19894220 |
| C038091 | butylparaben | butylparaben results in decreased expression of RUNX2 mRNA | 28527915 |
| D002104 | Cadmium | Cadmium results in decreased expression of RUNX2 mRNA | 20570719 |
| D019256 | Cadmium Chloride | Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of RUNX2 mRNA] | 19017541 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of RUNX2 | 22019892 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of RUNX2 mRNA | 19017541|2559613 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in decreased expression of RUNX2 protein] | 28363435 |
| C058819 | calphostin C | calphostin C inhibits the reaction [FGF2 protein results in increased expression of and results in increased activity of RUNX2 protein] | 12403780 |
| C058819 | calphostin C | calphostin C inhibits the reaction [FGF2 protein results in increased expression of RUNX2 mRNA] | 12403780 |
| D002164 | Camphor | Camphor analog affects the expression of RUNX2 mRNA | 24704097 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of RUNX2 mRNA | 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of RUNX2 mRNA | 17334410 |
| D002251 | Carbon Tetrachloride | FR 167653 inhibits the reaction [Carbon Tetrachloride results in increased expression of RUNX2 mRNA] | 17334410 |
| D000068579 | Celecoxib | [Celecoxib results in decreased activity of PTGS2 protein] which results in decreased expression of RUNX2 mRNA | 27050768 |
| D000068579 | Celecoxib | [Celecoxib results in decreased activity of PTGS2 protein] which results in decreased expression of RUNX2 protein | 27050768 |
| D048271 | Chitosan | Chitosan results in increased expression of RUNX2 mRNA | 25246786 |
| D048271 | Chitosan | Chitosan results in increased expression of RUNX2 protein | 25246786 |
| C004656 | chloroacetaldehyde | chloroacetaldehyde results in decreased expression of RUNX2 mRNA | 25596134 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RUNX2 mRNA | 20938992 |
| C022990 | chromic chloride | [cobaltous chloride co-treated with chromic chloride] affects the expression of RUNX2 mRNA | 25966675 |
| D002858 | Chromium Alloys | Chromium Alloys results in decreased expression of RUNX2 mRNA | 25966675 |
| C059262 | cidofovir | cidofovir results in increased expression of RUNX2 mRNA | 25596134 |
| D004002 | Clodronic Acid | Clodronic Acid results in increased expression of RUNX2 mRNA | 25596134 |
| C007095 | cobaltiprotoporphyrin | [cobaltiprotoporphyrin co-treated with IL1B protein] results in increased expression of RUNX2 mRNA | 22155307 |
| C018021 | cobaltous chloride | cobaltous chloride affects the expression of RUNX2 mRNA | 25966675 |
| C018021 | cobaltous chloride | [cobaltous chloride co-treated with chromic chloride] affects the expression of RUNX2 mRNA | 25966675 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of RUNX2 mRNA | 16772336 |
| D005576 | Colforsin | Colforsin results in increased expression of RUNX2 mRNA | 20197312 |
| D003300 | Copper | [Copper co-treated with Dietary Sucrose] results in increased expression of RUNX2 mRNA | 26033743 |
| D003300 | Copper | Copper deficiency results in increased expression of RUNX2 mRNA | 26033743 |
| D065366 | Cryptoxanthins | [Cryptoxanthins co-treated with Vitamin A] results in increased expression of RUNX2 mRNA | 15962303 |
| D065366 | Cryptoxanthins | Cryptoxanthins results in increased expression of RUNX2 mRNA | 15962303 |
| D065366 | Cryptoxanthins | Cycloheximide inhibits the reaction [Cryptoxanthins results in increased expression of RUNX2 mRNA] | 15962303 |
| D065366 | Cryptoxanthins | Dichlororibofuranosylbenzimidazole inhibits the reaction [Cryptoxanthins results in increased expression of RUNX2 mRNA] | 15962303 |
| D003474 | Curcumin | Curcumin results in decreased expression of RUNX2 protein | 15129424 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Cryptoxanthins results in increased expression of RUNX2 mRNA] | 15962303 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Zinc Sulfate results in increased expression of RUNX2 mRNA] | 18327666 |
| D003634 | DDT | DDT results in increased expression of RUNX2 mRNA | 25014179 |
| D003676 | Deferoxamine | Deferoxamine results in decreased expression of RUNX2 mRNA | 16772336 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of RUNX2 mRNA | 25286332|2646816 |
| D003907 | Dexamethasone | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA | 26424790 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of RUNX2 mRNA | 25047013 |
| D003907 | Dexamethasone | EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA] | 26424790 |
| D003907 | Dexamethasone | Acetylcysteine inhibits the reaction [Dexamethasone affects the expression of RUNX2 mRNA] | 24239970 |
| D003907 | Dexamethasone | [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA | 27028516 |
| D003907 | Dexamethasone | caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in decreased expression of RUNX2 protein] | 28363435 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of RUNX2 mRNA | 24239970 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein] | 27387537 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of RUNX2 mRNA | 27387537 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of RUNX2 protein | 27387537|2836343 |
| D003907 | Dexamethasone | ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]] | 27387537 |
| D003907 | Dexamethasone | ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of RUNX2 mRNA] | 27387537 |
| D003907 | Dexamethasone | ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of RUNX2 protein] | 27387537 |
| D003907 | Dexamethasone | Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA] | 27028516 |
| D003907 | Dexamethasone | NOG protein inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]]] | 27387537 |
| D003907 | Dexamethasone | Quercetin affects the reaction [Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA]] | 27028516 |
| D002945 | Cisplatin | Cisplatin affects the expression of RUNX2 mRNA | 25596134 |
| D002945 | Cisplatin | Cisplatin promotes the reaction [jinfukang results in decreased expression of RUNX2 mRNA] | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of RUNX2 mRNA | 27392435 |
| D002945 | Cisplatin | jinfukang promotes the reaction [Cisplatin results in decreased expression of RUNX2 mRNA] | 27392435 |
| D004004 | Dichlororibofuranosylbenzimidazole | Dichlororibofuranosylbenzimidazole inhibits the reaction [Cryptoxanthins results in increased expression of RUNX2 mRNA] | 15962303 |
| D004004 | Dichlororibofuranosylbenzimidazole | Dichlororibofuranosylbenzimidazole inhibits the reaction [Zinc Sulfate results in increased expression of RUNX2 mRNA] | 18327666 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of RUNX2 mRNA | 26924002 |
| D019422 | Dietary Sucrose | [Copper co-treated with Dietary Sucrose] results in increased expression of RUNX2 mRNA | 26033743 |
| D019422 | Dietary Sucrose | Dietary Sucrose results in increased expression of RUNX2 mRNA | 26033743 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of RUNX2 protein | 22985736 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of RUNX2 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RUNX2 mRNA | 22129741 |
| D004075 | Diglycerides | Diglycerides results in increased expression of RUNX2 mRNA | 22286232 |
| D002117 | Calcitriol | Calcitriol promotes the reaction [VDR protein binds to RUNX2 enhancer] | 17293108 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of RUNX2 mRNA | 16002434|2648566 |
| D002117 | Calcitriol | Calcitriol results in increased expression of RUNX2 mRNA | 21542014|2810541 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of RUNX2 mRNA | 17293108 |
| D002117 | Calcitriol | Calcitriol results in increased expression of RUNX2 protein | 19092814 |
| C024629 | dimethyl phthalate | dimethyl phthalate affects the expression of RUNX2 mRNA | 26924002 |
| D004221 | Disulfiram | Disulfiram results in increased expression of RUNX2 mRNA | 24496638 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of RUNX2 mRNA" | 16543677 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid results in decreased expression of RUNX2 mRNA | 21193197 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RUNX2 mRNA | 22079256 |
| D004967 | Estrogens | Estrogens results in increased expression of RUNX2 mRNA | 25014179 |
| D004967 | Estrogens | Estrogens affects the expression of RUNX2 mRNA | 24098073 |
| D000431 | Ethanol | [Genistein co-treated with Ethanol] results in increased expression of RUNX2 mRNA | 24872432 |
| D000431 | Ethanol | [Genistein co-treated with Ethanol] results in increased expression of RUNX2 protein | 24872432 |
| C034096 | ethoxyacetic acid | ethoxyacetic acid affects the expression of RUNX2 mRNA | 24704097 |
| C004808 | farnesyl pyrophosphate | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] | 18310456 |
| D005419 | Flavonoids | Flavonoids results in increased expression of RUNX2 mRNA | 16543677|2323899 |
| D005459 | Fluorides | Fluorides results in increased expression of RUNX2 mRNA | 20709135 |
| D005459 | Fluorides | Fluorides inhibits the reaction [potassium phosphate results in increased expression of RUNX2 mRNA] | 24561004 |
| D005472 | Fluorouracil | Fluorouracil affects the expression of RUNX2 mRNA | 24704097 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RUNX2 mRNA | 20938992 |
| C104334 | FR 167653 | FR 167653 inhibits the reaction [Carbon Tetrachloride results in increased expression of RUNX2 mRNA] | 17334410 |
| C069837 | fullerene C60 | fullerene C60 results in increased expression of RUNX2 mRNA | 19167457 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased expression of RUNX2 mRNA] | 17689939 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [notoginsenoside R1 results in increased expression of RUNX2 mRNA] | 26362186 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [resveratrol results in increased expression of RUNX2 mRNA] | 17689939 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [naringin results in increased expression of RUNX2 mRNA] | 23596885 |
| C057580 | gallocatechol | gallocatechol results in increased expression of RUNX2 mRNA | 21877759 |
| C013172 | gamma-oryzanol | gamma-oryzanol affects the expression of RUNX2 mRNA | 24098073 |
| D019833 | Genistein | Genistein affects the expression of RUNX2 mRNA | 17166402 |
| D019833 | Genistein | [Genistein co-treated with Ethanol] results in increased expression of RUNX2 mRNA | 24872432 |
| D019833 | Genistein | [Genistein co-treated with Ethanol] results in increased expression of RUNX2 protein | 24872432 |
| D019833 | Genistein | Genistein results in increased expression of RUNX2 mRNA | 24872432 |
| D019833 | Genistein | Genistein results in increased expression of RUNX2 protein | 24872432 |
| D019833 | Genistein | Genistein results in increased expression of RUNX2 mRNA | 21877759 |
| C002963 | geranylgeranyl pyrophosphate | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] | 18310456 |
| C112485 | ginkgolic acid | ginkgolic acid inhibits the reaction [Tretinoin results in increased expression of RUNX2 mRNA] | 24819975 |
| C442759 | ginsenoside Rb1 | ginsenoside Rb1 inhibits the reaction [aluminum chloride results in decreased expression of RUNX2 mRNA] | 27470910 |
| C442759 | ginsenoside Rb1 | ginsenoside Rb1 results in increased expression of RUNX2 mRNA | 27470910 |
| C097367 | ginsenoside Rg3 | ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]] | 27387537 |
| C097367 | ginsenoside Rg3 | ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of RUNX2 mRNA] | 27387537 |
| C097367 | ginsenoside Rg3 | ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of RUNX2 protein] | 27387537 |
| C097367 | ginsenoside Rg3 | NOG protein inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]]] | 27387537 |
| D005944 | Glucosamine | "4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased phosphorylation of RUNX2 protein]" | 20458730 |
| D005944 | Glucosamine | Glucosamine analog results in increased expression of RUNX2 mRNA | 20458730 |
| D005944 | Glucosamine | Glucosamine analog results in increased phosphorylation of RUNX2 protein | 20458730 |
| D005947 | Glucose | Glucose results in increased expression of RUNX2 mRNA | 17178593 |
| D005960 | Glucosides | Glucosides analog affects the expression of RUNX2 mRNA | 24098073 |
| C004312 | glycidol | glycidol results in increased expression of RUNX2 mRNA | 24915197 |
| C529769 | GSK0660 | GSK0660 inhibits the reaction [Bezafibrate results in increased expression of RUNX2 mRNA] | 21499286 |
| C577920 | GSK126 | GSK126 results in increased expression of RUNX2 mRNA | 26424790 |
| C409722 | hexaconazole | hexaconazole affects the expression of RUNX2 mRNA | 24704097 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of RUNX2 mRNA | 17183249 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of RUNX2 protein | 17183249 |
| D006861 | Hydrogen Peroxide | DKK1 protein inhibits the reaction [naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of RUNX2 mRNA]] | 26482937 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of RUNX2 mRNA | 26482937 |
| D006861 | Hydrogen Peroxide | naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of RUNX2 mRNA] | 26482937 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA] | 27028516 |
| D006861 | Hydrogen Peroxide | Quercetin affects the reaction [Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA]] | 27028516 |
| C031927 | hydroquinone | hydroquinone results in increased expression of RUNX2 mRNA | 22960397 |
| D002112 | Calcifediol | Calcifediol results in increased expression of RUNX2 mRNA | 21542014 |
| D002112 | Calcifediol | CYP27B1 protein promotes the reaction [Calcifediol results in increased expression of RUNX2 mRNA] | 21542014 |
| D002112 | Calcifediol | Ketoconazole inhibits the reaction [Calcifediol results in increased expression of RUNX2 mRNA] | 21542014 |
| D006918 | Hydroxyurea | Hydroxyurea affects the expression of RUNX2 mRNA | 24704097 |
| C056599 | icariin | icariin results in increased expression of RUNX2 mRNA | 18295595|1974780 |
| C056599 | icariin | NOG protein inhibits the reaction [icariin results in increased expression of RUNX2 mRNA] | 18295595|1974780 |
| C056599 | icariin | icariin results in increased expression of RUNX2 mRNA | 20019778 |
| C016517 | indole-3-carbinol | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RUNX2 mRNA | 22129741 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of RUNX2 mRNA | 25613284 |
| C027681 | isonicotinamide | isonicotinamide results in increased expression of RUNX2 mRNA | 21745208 |
| C544151 | jinfukang | Cisplatin promotes the reaction [jinfukang results in decreased expression of RUNX2 mRNA] | 27392435 |
| C544151 | jinfukang | jinfukang promotes the reaction [Cisplatin results in decreased expression of RUNX2 mRNA] | 27392435 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound inhibits the reaction [BRD4 protein binds to RUNX2 gene] | 25944566 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound inhibits the reaction [BRD4 protein binds to RUNX2 promoter] | 25307878 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of RUNX2 mRNA | 23129625|2464647 |
| C561695 | (+)-JQ1 compound | RUNX2 mutant form promotes the reaction [(+)-JQ1 compound results in increased expression of CDKN1A protein] | 25307878 |
| C561695 | (+)-JQ1 compound | RUNX2 protein inhibits the reaction [(+)-JQ1 compound results in increased expression of CDKN1A protein] | 25307878 |
| C561695 | (+)-JQ1 compound | RUNX2 protein results in decreased susceptibility to (+)-JQ1 compound | 25307878 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of RUNX2 mRNA | 24646477|2594456 |
| C006552 | kaempferol | kaempferol results in increased expression of RUNX2 mRNA | 23989061 |
| D007654 | Ketoconazole | Ketoconazole inhibits the reaction [Calcifediol results in increased expression of RUNX2 mRNA] | 21542014 |
| D007854 | Lead | Lead results in decreased expression of RUNX2 mRNA | 23086611 |
| D007854 | Lead | Lead results in decreased expression of RUNX2 mRNA | 23086611 |
| D007854 | Lead | Lead results in decreased expression of RUNX2 protein | 23086611 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 inhibits the reaction [BMP2 protein results in increased expression of RUNX2 protein]" | 26961602 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "MIR23B mRNA inhibits the reaction [lipopolysaccharide, E coli O55-B5 inhibits the reaction [BMP2 protein results in increased expression of RUNX2 protein]]" | 26961602 |
| D019808 | Losartan | Losartan affects the reaction [[Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 mRNA] | 27412937 |
| D019808 | Losartan | Losartan affects the reaction [[Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 protein] | 27412937 |
| D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RUNX2 mRNA | 21641980 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RUNX2 mRNA | 26378955 |
| D008550 | Melatonin | Melatonin results in increased expression of RUNX2 mRNA | 20738756 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| D008687 | Metformin | Metformin results in increased expression of RUNX2 protein | 19594306 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RUNX2 mRNA | 20938992 |
| D008727 | Methotrexate | RUNX2 mRNA results in decreased susceptibility to Methotrexate | 20008919 |
| D008731 | Methoxychlor | Methoxychlor results in decreased expression of RUNX2 mRNA | 23303685 |
| D008731 | Methoxychlor | Methoxychlor results in increased methylation of RUNX2 gene | 23303685 |
| C015358 | methylparaben | methylparaben results in decreased expression of RUNX2 mRNA | 28527915 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of RUNX2 mRNA | 20197312 |
| C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in decreased expression of RUNX2 mRNA | 22401849|2577708 |
| C028577 | monobutyl phthalate | monobutyl phthalate affects the expression of RUNX2 mRNA | 24704097 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of RUNX2 mRNA | 26924002 |
| C093875 | montelukast | montelukast results in increased expression of RUNX2 mRNA | 19544365 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased expression of RUNX2 mRNA | 27050768 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased expression of RUNX2 protein | 27050768 |
| C005274 | naringin | DKK1 protein inhibits the reaction [naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of RUNX2 mRNA]] | 26482937 |
| C005274 | naringin | naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of RUNX2 mRNA] | 26482937 |
| C005274 | naringin | naringin results in increased expression of RUNX2 mRNA | 24915843 |
| C005274 | naringin | naringin results in increased expression of RUNX2 mRNA | 21741227 |
| C005274 | naringin | fulvestrant inhibits the reaction [naringin results in increased expression of RUNX2 mRNA] | 23596885 |
| C005274 | naringin | naringin results in increased expression of RUNX2 mRNA | 23596885 |
| C553460 | neoeriocitrin | neoeriocitrin results in increased expression of RUNX2 mRNA | 21741227 |
| C028007 | nickel monoxide | nickel monoxide results in increased expression of RUNX2 mRNA | 19167457 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "[zinc chloride co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased expression of RUNX2 protein" | 19913120 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of RUNX2 mRNA" | 19913120 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of RUNX2 protein" | 19913120 |
| C072936 | notoginsenoside R1 | fulvestrant inhibits the reaction [notoginsenoside R1 results in increased expression of RUNX2 mRNA] | 26362186 |
| C072936 | notoginsenoside R1 | notoginsenoside R1 results in increased expression of RUNX2 mRNA | 26362186 |
| C510784 | ormosil | [ormosil binds to Polyethylene Glycols] which results in increased expression of RUNX2 mRNA | 24888373 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of RUNX2 mRNA | 25596134 |
| D019308 | Palmitic Acid | acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of RUNX2 mRNA] | 24080574 |
| D019308 | Palmitic Acid | CYBA mutant form inhibits the reaction [Palmitic Acid results in increased expression of RUNX2 mRNA] | 24080574 |
| D019308 | Palmitic Acid | Palmitic Acid results in increased expression of RUNX2 mRNA | 24080574 |
| D019308 | Palmitic Acid | U 0126 inhibits the reaction [Palmitic Acid results in increased expression of RUNX2 mRNA] | 24080574 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RUNX2 mRNA" | 25510870 |
| D015232 | Dinoprostone | Dinoprostone results in increased expression of RUNX2 mRNA | 27050768 |
| D015232 | Dinoprostone | Dinoprostone results in increased expression of RUNX2 protein | 27050768 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of RUNX2 mRNA | 26272509 |
| D010710 | Phosphates | [Ascorbic Acid co-treated with Phosphates] results in increased expression of RUNX2 mRNA | 21613385 |
| D010710 | Phosphates | Phosphates results in decreased expression of RUNX2 mRNA | 26111760 |
| D010936 | Plant Extracts | Plant Extracts affects the expression of RUNX2 mRNA | 24098073 |
| C061957 | polaprezinc | polaprezinc results in increased expression of RUNX2 mRNA | 18327666 |
| D011092 | Polyethylene Glycols | [ormosil binds to Polyethylene Glycols] which results in increased expression of RUNX2 mRNA | 24888373 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RUNX2 mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of RUNX2 mRNA | 22079256 |
| C013216 | potassium phosphate | Fluorides inhibits the reaction [potassium phosphate results in increased expression of RUNX2 mRNA] | 24561004 |
| C013216 | potassium phosphate | potassium phosphate results in increased expression of RUNX2 mRNA | 24561004 |
| D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in decreased expression of RUNX2 mRNA | 20660070 |
| D015237 | Dinoprost | Dinoprost results in increased expression of RUNX2 mRNA | 27050768 |
| D015237 | Dinoprost | Dinoprost results in increased expression of RUNX2 protein | 27050768 |
| C432165 | pyrazolanthrone | [pyrazolanthrone co-treated with SB 203580 co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] inhibits the reaction [Quercetin results in increased expression of RUNX2 mRNA] | 26136938 |
| D011794 | Quercetin | Quercetin results in increased expression of RUNX2 mRNA | 16996034 |
| D011794 | Quercetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased expression of RUNX2 mRNA] | 26053266|2613693 |
| D011794 | Quercetin | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quercetin results in increased expression of RUNX2 mRNA] | 26053266 |
| D011794 | Quercetin | [pyrazolanthrone co-treated with SB 203580 co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] inhibits the reaction [Quercetin results in increased expression of RUNX2 mRNA] | 26136938 |
| D011794 | Quercetin | Quercetin affects the reaction [Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of RUNX2 mRNA]] | 27028516 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[Warfarin co-treated with Vitamin K] results in increased expression of RUNX2 mRNA] | 23117658 |
| D011794 | Quercetin | Quercetin results in increased expression of RUNX2 mRNA | 17243115|2605326 |
| C004532 | quinone | quinone results in increased expression of RUNX2 mRNA | 22960397 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride affects the expression of RUNX2 mRNA | 17166402 |
| C073419 | Remifemin | Remifemin affects the expression of RUNX2 mRNA | 24098073 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]] | 22539994 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein] | 22539994 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Niacinamide results in increased acetylation of RUNX2 protein] | 22539994 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TNFSF11 protein results in decreased expression of RUNX2 protein] | 21239502 |
| C059514 | resveratrol | resveratrol promotes the reaction [[SIRT1 protein binds to EP300 protein] which binds to RUNX2 protein] | 21239502 |
| C059514 | resveratrol | resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein] | 21239502 |
| C059514 | resveratrol | resveratrol results in decreased acetylation of RUNX2 protein | 22539994 |
| C059514 | resveratrol | [resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to RUNX2 protein] | 22539994 |
| C059514 | resveratrol | resveratrol results in increased expression of RUNX2 protein | 22539994 |
| C059514 | resveratrol | SIRT1 protein affects the reaction [resveratrol results in decreased acetylation of RUNX2 protein] | 22539994 |
| C059514 | resveratrol | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of RUNX2 mRNA] | 17689939 |
| C059514 | resveratrol | fulvestrant inhibits the reaction [resveratrol results in increased expression of RUNX2 mRNA] | 17689939 |
| C059514 | resveratrol | resveratrol promotes the reaction [[SIRT1 protein binds to FOXO3 protein] which binds to RUNX2 3' UTR] | 21713995 |
| C059514 | resveratrol | resveratrol promotes the reaction [[[SIRT1 protein binds to FOXO3 protein] which binds to RUNX2 3' UTR] which results in increased expression of RUNX2 mRNA] | 21713995|2171399 |
| C059514 | resveratrol | resveratrol results in increased expression of RUNX2 mRNA | 17689939|2171399 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein] | 22539994 |
| C059514 | resveratrol | resveratrol results in increased expression of RUNX2 mRNA | 19665018 |
| C059514 | resveratrol | resveratrol results in increased expression of RUNX2 mRNA | 16813520 |
| C059514 | resveratrol | [resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [Niacinamide results in increased expression of PPARG] | 22539994 |
| C059514 | resveratrol | [resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] which results in decreased activity of NCOR1 protein | 22539994 |
| C059514 | resveratrol | [resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [Niacinamide results in increased expression of PPARG] | 22539994 |
| C059514 | resveratrol | [resveratrol results in decreased acetylation of RUNX2 protein] which affects the activity of NCOR1 protein | 22539994 |
| C009172 | rhodioloside | rhodioloside results in increased activity of RUNX2 protein | 24055767 |
| C009172 | rhodioloside | rhodioloside results in increased expression of RUNX2 mRNA | 24055767 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of RUNX2 | 17993761 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of RUNX2 mRNA | 12021203|1450057 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of RUNX2 mRNA | 15591153 |
| C085746 | rottlerin | rottlerin inhibits the reaction [FGF2 protein results in increased activity of RUNX2 protein] | 12403780 |
| C085746 | rottlerin | rottlerin inhibits the reaction [FGF2 protein results in increased expression of RUNX2 mRNA] | 12403780 |
| C093642 | SB 203580 | [pyrazolanthrone co-treated with SB 203580 co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] inhibits the reaction [Quercetin results in increased expression of RUNX2 mRNA] | 26136938 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of RUNX2 mRNA | 25895662 |
| D019821 | Simvastatin | Simvastatin results in increased expression of RUNX2 | 20381859 |
| D019821 | Simvastatin | DKK1 inhibits the reaction [Simvastatin results in increased expression of RUNX2 mRNA] | 22058016 |
| D019821 | Simvastatin | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] | 18310456 |
| D019821 | Simvastatin | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]]] | 18310456 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA] | 18310456 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [TNF protein inhibits the reaction [BMP2 results in increased expression of RUNX2 mRNA]] | 18310456 |
| D019821 | Simvastatin | Simvastatin results in increased expression of RUNX2 mRNA | 20417880|2205801 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of RUNX2 mRNA | 28206643 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in decreased expression of RUNX2 mRNA | 26339601 |
| D012969 | Sodium Fluoride | [Sodium Fluoride co-treated with aluminum chloride] results in increased expression of RUNX2 mRNA | 21560300 |
| D012969 | Sodium Fluoride | DKK1 protein inhibits the reaction [Sodium Fluoride results in increased expression of RUNX2 mRNA] | 24300170 |
| D012969 | Sodium Fluoride | DKK1 protein inhibits the reaction [Sodium Fluoride results in increased expression of RUNX2 protein] | 24300170 |
| D012969 | Sodium Fluoride | Sodium Fluoride affects the expression of RUNX2 mRNA | 25132241 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of RUNX2 mRNA | 24300170 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of RUNX2 protein | 24300170 |
| D053260 | Soot | Soot results in decreased expression of RUNX2 mRNA | 23634900 |
| D013311 | Streptozocin | Streptozocin results in decreased expression of RUNX2 mRNA | 25617479 |
| D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RUNX2 mRNA | 21641980 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RUNX2 mRNA | 26378955 |
| C446685 | systhane | systhane affects the expression of RUNX2 mRNA | 24704097 |
| D016559 | Tacrolimus | Tacrolimus results in decreased expression of RUNX2 mRNA | 15780950 |
| C061133 | tamibarotene | tamibarotene results in decreased expression of RUNX2 mRNA | 15498508 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in decreased expression of RUNX2 mRNA | 25777084 |
| D013749 | Tetrachlorodibenzodioxin | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RUNX2 mRNA] | 23625689 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of RUNX2 mRNA | 22903824|2362568 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of RUNX2 mRNA] | 19264158 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of RUNX2 mRNA | 24704097 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RUNX2 gene] | 20819909 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of RUNX2 mRNA | 19264158|2405805 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of RUNX2 mRNA | 17586704|2081990 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of RUNX2 mRNA | 28077779 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of RUNX2 mRNA | 19201780|1926415 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of RUNX2 mRNA | 27913140 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of RUNX2 mRNA | 25613284 |
| D013893 | Thiram | Thiram results in decreased expression of RUNX2 mRNA | 24235232 |
| D013893 | Thiram | VEGFA protein affects the reaction [Thiram results in decreased expression of RUNX2 mRNA] | 24235232 |
| D013928 | Thromboxane A2 | Thromboxane A2 results in increased expression of RUNX2 mRNA | 27050768 |
| D013928 | Thromboxane A2 | Thromboxane A2 results in increased expression of RUNX2 protein | 27050768 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of RUNX2 mRNA | 18087596 |
| D014212 | Tretinoin | anacardic acid inhibits the reaction [Tretinoin results in increased expression of RUNX2 mRNA] | 24819975 |
| D014212 | Tretinoin | ginkgolic acid inhibits the reaction [Tretinoin results in increased expression of RUNX2 mRNA] | 24819975 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of RUNX2 mRNA | 15498508 |
| D014212 | Tretinoin | Tretinoin results in increased expression of RUNX2 mRNA | 21934132|2481997 |
| D014212 | Tretinoin | Tretinoin results in increased expression of RUNX2 mRNA | 16350840 |
| C011559 | tributyltin | tributyltin results in decreased expression of RUNX2 mRNA | 23322813|2451344 |
| C012589 | trichostatin A | trichostatin A results in increased expression of RUNX2 mRNA | 24935251 |
| C053549 | triflumizol | triflumizol results in decreased expression of RUNX2 mRNA | 23086663 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in increased expression of RUNX2 mRNA | 19042947 |
| C057693 | troglitazone | troglitazone results in decreased expression of RUNX2 mRNA | 16813520|1912227 |
| C057693 | troglitazone | troglitazone inhibits the reaction [BMP2 protein results in increased expression of RUNX2 mRNA] | 19122273 |
| D014414 | Tungsten | Tungsten results in decreased expression of RUNX2 mRNA | 26865663 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 results in decreased expression of RUNX2 mRNA | 20197312 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Ascorbic Acid results in increased expression of RUNX2 mRNA] | 20530736 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Palmitic Acid results in increased expression of RUNX2 mRNA] | 24080574 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased methylation of RUNX2 gene | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of RUNX2 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of RUNX2 mRNA | 23042728 |
| D014638 | Vanadates | Vanadates results in increased expression of RUNX2 mRNA | 22714537 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of RUNX2 gene | 25560391 |
| D014801 | Vitamin A | [Cryptoxanthins co-treated with Vitamin A] results in increased expression of RUNX2 mRNA | 15962303 |
| D012256 | Riboflavin | Riboflavin analog results in increased expression of RUNX2 protein | 20688149 |
| D009536 | Niacinamide | Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein] | 22539994 |
| D009536 | Niacinamide | Niacinamide results in decreased expression of RUNX2 protein | 22539994 |
| D009536 | Niacinamide | Niacinamide results in increased acetylation of RUNX2 protein | 22539994 |
| D009536 | Niacinamide | resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]] | 22539994 |
| D009536 | Niacinamide | resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein] | 22539994 |
| D009536 | Niacinamide | resveratrol inhibits the reaction [Niacinamide results in increased acetylation of RUNX2 protein] | 22539994 |
| D009536 | Niacinamide | Niacinamide results in decreased expression of RUNX2 mRNA | 16813520 |
| D009536 | Niacinamide | Niacinamide results in decreased expression of RUNX2 protein | 22539994 |
| D009536 | Niacinamide | resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein] | 22539994 |
| D009536 | Niacinamide | Niacinamide results in increased expression of RUNX2 mRNA | 16813520 |
| D009536 | Niacinamide | [resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [Niacinamide results in increased expression of PPARG] | 22539994 |
| D009536 | Niacinamide | [resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [Niacinamide results in increased expression of PPARG] | 22539994 |
| D002762 | Cholecalciferol | [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of RUNX2 mRNA | 17692823 |
| D014812 | Vitamin K | Quercetin inhibits the reaction [[Warfarin co-treated with Vitamin K] results in increased expression of RUNX2 mRNA] | 23117658 |
| D014812 | Vitamin K | [Warfarin co-treated with Vitamin K] results in increased expression of RUNX2 mRNA | 23117658 |
| D010837 | Vitamin K 1 | Losartan affects the reaction [[Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 mRNA] | 27412937 |
| D010837 | Vitamin K 1 | Losartan affects the reaction [[Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 protein] | 27412937 |
| D010837 | Vitamin K 1 | [Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 mRNA | 27412937 |
| D010837 | Vitamin K 1 | [Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 protein | 27412937 |
| D014859 | Warfarin | Warfarin inhibits the reaction [BMP2 protein results in increased activity of RUNX2 protein] | 21910061 |
| D014859 | Warfarin | Warfarin inhibits the reaction [RUNX2 protein results in increased expression of ALPL mRNA] | 21910061 |
| D014859 | Warfarin | Warfarin inhibits the reaction [RUNX2 protein results in increased expression of BGLAP mRNA] | 21910061 |
| D014859 | Warfarin | Losartan affects the reaction [[Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 mRNA] | 27412937 |
| D014859 | Warfarin | Losartan affects the reaction [[Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 protein] | 27412937 |
| D014859 | Warfarin | Quercetin inhibits the reaction [[Warfarin co-treated with Vitamin K] results in increased expression of RUNX2 mRNA] | 23117658 |
| D014859 | Warfarin | [Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 mRNA | 27412937 |
| D014859 | Warfarin | [Warfarin co-treated with Vitamin K 1] affects the expression of RUNX2 protein | 27412937 |
| D014859 | Warfarin | [Warfarin co-treated with Vitamin K] results in increased expression of RUNX2 mRNA | 23117658 |
| D015032 | Zinc | Zinc deficiency results in decreased expression of RUNX2 mRNA | 21893222 |
| D015032 | Zinc | Zinc deficiency results in decreased expression of RUNX2 protein | 21893222 |
| C016837 | zinc chloride | "[zinc chloride co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased expression of RUNX2 protein" | 19913120 |
| C016837 | zinc chloride | "[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of RUNX2 mRNA" | 19913120 |
| C016837 | zinc chloride | "[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of RUNX2 protein" | 19913120 |
| D019287 | Zinc Sulfate | Cycloheximide inhibits the reaction [Zinc Sulfate results in increased expression of RUNX2 mRNA] | 18327666 |
| D019287 | Zinc Sulfate | Dichlororibofuranosylbenzimidazole inhibits the reaction [Zinc Sulfate results in increased expression of RUNX2 mRNA] | 18327666 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in increased expression of RUNX2 mRNA | 18327666 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of RUNX2 mRNA | 25596134 |